Whistleblower: Pfizer COVID-19 vaccine has serious violations in Texas trials
- Normal Liver Cells Found to Promote Cancer Metastasis to the Liver
- Nearly 80% Complete Remission: Breakthrough in ADC Anti-Tumor Treatment
- Vaccination Against Common Diseases May Prevent Dementia!
- New Alzheimer’s Disease (AD) Diagnosis and Staging Criteria
- Breakthrough in Alzheimer’s Disease: New Nasal Spray Halts Cognitive Decline by Targeting Toxic Protein
- Can the Tap Water at the Paris Olympics be Drunk Directly?
Whistleblower: Pfizer COVID-19 vaccine has serious violations in Texas trials
- Should China be held legally responsible for the US’s $18 trillion COVID losses?
- CT Radiation Exposure Linked to Blood Cancer in Children and Adolescents
- FDA has mandated a top-level black box warning for all marketed CAR-T therapies
- Can people with high blood pressure eat peanuts?
- What is the difference between dopamine and dobutamine?
- How long can the patient live after heart stent surgery?
Whistleblower: Pfizer COVID-19 vaccine has serious violations in Texas trials.
On November 3, reported that the British Medical Journal (BMJ) quoted Brooke Jackson, the former regional director of Ventavia Research in the United States, as saying that in the fall of 2020, Ventavia will conduct a trial for Pfizer’s COVID-19 vaccine in Texas. There are serious violations in.
Pfizer’s COVID-19 vaccine.
The magazine wrote: “Jackson disclosed to the British Medical Journal that Ventavia had falsified data, informed in advance that trial participants would be given the real vaccine or a placebo, used inadequately trained vaccinators, and had a negative impact on Pfizer’s Phase 3 vaccine. Follow-up of adverse reactions reported during the main study period is slow.”
According to the magazine, after informing Ventavia of these issues several times, Jackson sent an e-mail complaint to the U.S. Food and Drug Administration (FDA). On the night of sending an email to the FDA, Jackson was fired by Ventavia.
Ventavia stated on its website that the company is the largest private clinical research company in Texas.
On December 11, 2020, the FDA approved an emergency use authorization application for Pfizer’s COVID-19 vaccine. In August of this year, after Pfizer’s vaccine was fully approved, the FDA released an inspection summary of the company’s key trials. The FDA inspected 9 of the 153 sites tested, but Ventavia was not among the 9 inspected sites.
(source:internet, reference only)
Disclaimer of medicaltrend.org
Important Note: The information provided is for informational purposes only and should not be considered as medical advice.